Literature DB >> 2645346

Identification of the fatality-prone subject with asthma.

R C Strunk1.   

Abstract

Entities:  

Mesh：

Year:  1989        PMID： 2645346     DOI： 10.1016/0091-6749(89)90137-1

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  9 in total

1.  A Randomized, Double-Blind, Placebo-Controlled Trial of Escitalopram in Patients with Asthma and Major Depressive Disorder.

Authors:  E Sherwood Brown; Nasreen Sayed; Erin Van Enkevort; Alexandra Kulikova; Alyson Nakamura; David A Khan; Elena I Ivleva; Prabha Sunderajan; Bruce G Bender; Traci Holmes
Journal:  J Allergy Clin Immunol Pract       Date:  2018-03-01

2.  Reducing morbidity and mortality due to asthma.

Authors:  O P Sharma
Journal:  West J Med       Date:  1989-11

3.  Treatment of chronic severe asthma.

Authors:  H A Boushey
Journal:  West J Med       Date:  1997-11

4.  Action plans in asthma management. Why, when, and how?

Authors:  S Janson
Journal:  West J Med       Date:  1996-09

5.  Severe acute asthma exacerbation in children: a stepwise approach for escalating therapy in a pediatric intensive care unit.

Authors:  I Federico Fernandez Nievas; Kanwaljeet J S Anand
Journal:  J Pediatr Pharmacol Ther       Date:  2013-04

6.  Case-control study of severe life threatening asthma (SLTA) in adults: psychological factors.

Authors:  J Kolbe; W Fergusson; M Vamos; J Garrett
Journal:  Thorax       Date:  2002-04       Impact factor: 9.139

7.  Grading asthma severity: using the APS component of the Apache II system.

Authors:  A C Day; A P Rankin; J A Judson
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

8.  Epidemiology of deaths from asthma in Pennsylvania, 1978-87.

Authors:  K M Kaplan
Journal:  Public Health Rep       Date:  1993 Jan-Feb       Impact factor: 2.792

Review 9.  Outpatient treatment of adult asthma.

Authors:  E C Kleerup; D P Tashkin
Journal:  West J Med       Date:  1995-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.